Recent Activity
-
AO 24-09 was posted on November 25, 2024 Favorable opinion regarding: a proposal for a municipal corporation to begin billing patients’ insurance plans—and waiving any patient cost- sharing amounts—for treatment-in-place emergency medical services without an associated ambulance transport.
-
AO 24-08 was posted on September 13, 2024 Unfavorable advisory opinion regarding an entity’s proposal to share a percentage of its savings with certain groups to which it provides coverage through Employer Group Waiver Plans.
-
AO 24-07 was posted on August 23, 2024 Favorable opinion regarding a proposed patient assistance program operated by a nonprofit grant-making organization.
-
AO 24-06 was posted on July 23, 2024 Unfavorable opinion regarding proposed assistance for fertility services for qualifying patients receiving a gene therapy treatment developed by a biotechnology company.
-
AO 24-05 was posted on July 22, 2024 Favorable in part and unfavorable in part opinion regarding proposed assistance for: (i) travel, lodging, meals, and associated expenses; and (ii) fertility preservation services for qualifying patients receiving one of two gene therapy treatments developed by a publicly traded biotechnology company.
-
AO 24-04 was posted on June 20, 2024 Favorable opinion regarding: (i) a limited-time program to refund, waive, or delay requiring receipt of payment for a drug in the event of an insurance reimbursement denial or delay; and (ii) certain discounts to the cost of the drug.
-
AO 24-03 was posted on June 17, 2024 Favorable opinion regarding assistance, including travel, lodging, meals, and associated expenses, provided by a pharmaceutical manufacturer to qualifying patients receiving its gene therapy product and their caregivers.